Suppr超能文献

团队运动运动员口服避孕药周期中的力量表现:一项横断面研究。

Strength Performance Across the Oral Contraceptive Cycle of Team Sport Athletes: A Cross-Sectional Study.

作者信息

Reif Astrid, Wessner Barbara, Haider Patricia, Tschan Harald, Triska Christoph

机构信息

Subunit Sports Medicine, Exercise Physiology and Prevention, Centre for Sport Science and University Sports, Institute of Sport Science, University of Vienna, Vienna, Austria.

出版信息

Front Physiol. 2021 Jul 1;12:658994. doi: 10.3389/fphys.2021.658994. eCollection 2021.

Abstract

Oral contraceptive pills (OCP) are very popular in female athletes not only for contraceptive effects but also due to the possibility of cycle manipulation. Moreover, it is debatable whether the manipulation of the menstrual cycle has a beneficial effect on exercise performance. Therefore, the aim of this study was to investigate potential differences in knee-extensor and flexor strength performance of first division team sport athletes between phases of the oral contraceptive cycle. Sixteen female handball players (age: 23.3 ± 3.1 years; body mass: 67.0 ± 8.52 kg; body stature: 1.68 ± 0.05 m) using a monophasic OCP participated in strength performance tests, once during OCP consumption (CONS) and once during withdrawal (WITH). Tests were performed on a dynamometer to measure knee-extensor and flexor maximal voluntary isokinetic and isometric torque. Prior to each test, body mass was assessed, and venous blood samples were collected. Wilcoxon signed-rank test and magnitude-based inferences have been conducted to analyze differences between WITH and CONS. Significance was accepted at < 0.05. No significant differences between oral contraceptive cycle phases of knee-extensor and flexor strength parameters and body mass have been indicated (all at > 0.05). Follicle-stimulating hormone (FSH) ( = 0.001) and luteinizing hormone ( = 0.013) were significantly higher in WITH, whereby estradiol and progesterone showed no significant difference between phases (both at > 0.05). These results support the notion that knee-extensor and flexor isokinetic and isometric strength performance does not differ between phases of oral contraceptive cycle in well-trained team sport athletes. OCP intake is suggested to cause a stable but downregulated hormone cycle, which has no effect on knee-extensor and flexor strength when comparing oral contraceptive cycle phases. Therefore, manipulation of the female cycle using OCP in order to achieve a higher knee-extensor and flexor strength performance does not seem to be justified; however, it is currently unclear if cycle manipulation might affect other physiological systems.

摘要

口服避孕药(OCP)在女性运动员中非常受欢迎,这不仅是因为其避孕效果,还因为它有可能调节月经周期。此外,月经周期的调节是否对运动表现有有益影响,这一点存在争议。因此,本研究的目的是调查甲级团队运动项目运动员在口服避孕药周期各阶段之间,其伸膝和屈膝力量表现的潜在差异。16名使用单相口服避孕药的女子手球运动员(年龄:23.3±3.1岁;体重:67.0±8.52千克;身高:1.68±0.05米)参加了力量表现测试,一次是在服用口服避孕药期间(CONS),一次是在停药期间(WITH)。测试在测力计上进行,以测量伸膝和屈膝的最大自愿等速和等长扭矩。每次测试前,评估体重并采集静脉血样。采用Wilcoxon符号秩检验和基于量级的推断来分析WITH和CONS之间的差异。显著性水平设定为<0.05时接受差异显著。研究表明,口服避孕药周期各阶段之间,伸膝和屈膝力量参数及体重均无显著差异(均>0.05)。促卵泡生成素(FSH)(=0.001)和促黄体生成素(=0.013)在WITH阶段显著更高,而雌二醇和孕酮在各阶段之间无显著差异(均>0.05)。这些结果支持了这样一种观点,即对于训练有素的团队运动项目运动员,口服避孕药周期各阶段之间伸膝和屈膝的等速和等长力量表现没有差异。建议口服避孕药的摄入会导致一个稳定但激素水平下调的周期,在比较口服避孕药周期各阶段时,这对伸膝和屈膝力量没有影响。因此,为了获得更高的伸膝和屈膝力量表现而使用口服避孕药来调节女性周期似乎没有道理;然而,目前尚不清楚周期调节是否会影响其他生理系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/8281678/563c756782b2/fphys-12-658994-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验